GlassScriptPhysician profile
Robert D Wood
NPI 1932128931
$5,043.31
in general payments reported to CMS, 2019-2025
33 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,263 · 2020: $572 · 2021: $763 · 2022: $969 · 2023: $673 · 2024: $457 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,401.94 | 2019-2022 | |
| Medtronic, INC. | $538.06 | 2021-2025 | Accurian, Intellis Adaptivestim, Synchromedii |
| Amgen INC. | $402.68 | 2019-2022 | |
| Painteq LLC | $383.71 | 2022-2023 | Painteq |
| Abbvie INC. | $217.99 | 2023-2025 | Botox, Ubrelvy |
| Teva Pharmaceuticals USA, INC. | $202.02 | 2019-2020 | |
| Biotronik Nro, INC. | $201.40 | 2023-2025 | Prospera, Biotronik |
| Relievant Medsystems, INC. | $197.77 | 2022 | |
| Saluda Medical Americas, INC. | $157.61 | 2023 | Evoke Scs |
| Merck Sharp & Dohme LLC | $141.84 | 2020-2025 | Bridion |
| Boston Scientific Corporation | $141.46 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Biohaven Pharmaceuticals, INC. | $135.41 | 2021 | |
| Stryker Corporation | $127.72 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $103.87 | 2022 | |
| Collegium Pharmaceutical, INC. | $97.32 | 2019-2023 | Belbuca |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $90.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $85.57 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $66.61 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $53.90 | 2025 | |
| Medtronic USA, INC. | $37.35 | 2020 | |
| Trevena, INC. | $34.60 | 2021 | |
| Pfizer INC. | $33.37 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $27.72 | 2024 | Iovera, Zilretta, Exparel |
| Almatica Pharma LLC | $24.98 | 2022 | |
| Nalu Medical, INC. | $21.28 | 2023 | Nalu Neurostimulation System |
| Ibsa Pharma INC. | $17.50 | 2021 | |
| Depuy Synthes Sales INC. | $17.20 | 2025 | Orthovisc |
| Nevro Corp. | $17.07 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.71 | 2019 | |
| Lundbeck LLC | $13.43 | 2021 | |
| Lilly USA, LLC | $13.21 | 2020 | |
| Team_makena_llc | $13.00 | 2019 | |
| Zyla Life Sciences, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.